Pharmacogenetics of cerebrovascular metabolism modulators in dementia due to Alzheimer’s disease
The aims of this study were to investigate risk factors for cognitive and functional decline among 193 patients with Alzheimer’s disease dementia (AD), and to conduct pharmacogenetic analysis on cerebrovascular metabolism modulators, taking into account APOE haplotypes and the genotypes of ACE, CETP...
Saved in:
| Main Author: | Fabricio Ferreira de Oliveira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2015-03-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000300259&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EEG SIGNAL ANALYSIS FOR CLASSIFYING ALZHEIMER’S AND FRONTOTEMPORAL DEMENTIA DISORDERS USING ENSEMBLE METHODS
by: G Sudha, et al.
Published: (2025-06-01) -
Assessing the metabolism of the olfactory circuit by use of 18F-FDG PET-CT imaging in patients suspected of suffering from Alzheimer’s disease or frontotemporal dementia
by: Daniël S. L. Loewenstein, et al.
Published: (2024-10-01) -
Language impairment in the moderate stage of dementia due to Alzheimer's disease
by: Karin Zazo ORTIZ, et al.
Published: (2021-06-01) -
Pharmacogenetics or predictive genetics? APOE testing blurs the lines
by: Stefania Zampatti, et al.
Published: (2025-07-01) -
Lithium and neuroprotection: a review of molecular targets and biological effects at subtherapeutic concentrations in preclinical models of Alzheimer’s disease
by: Vanessa de Jesus R. De-Paula, et al.
Published: (2025-05-01)